A new report, another on the subject of renal denervation(RDN), claims the world market for these devices is predicted to grow from USD 88.5 million in 2012 to USD 1.9 billion by end 2021, at a CAGR of 41.2%. Like another recent offering, this one also says the market is being driven by rising hypertension incidence rates and the overall ageing of the global population.
A new report “Renal Denervation Devices Market – Global Industry Analysis, Size, Share, Growth, And Forecast, 2012 – 2021” elaborated by Transparency Market Research analyses the performance of the world renal denervation devices industry, providing market size estimates and forecasts for the period from 2012 up to 2021.
Geography-wise, Europe (notably Germany, France, the UK and Italy), followed by the Asia-Pacific, takes the obvious lead, accounting for over 80% of the global market share with the trend set to continue up to 2021.
On the claims that rising hypertension rates will drive the market, combined with an ageing population, we weren’t convinced the other day when we saw this mooted in another report… and we’re still not. But what do we know? Our two penny’s worth would say the blood pressure opportunity is indeed big and growing, but growth in sales will surely come from a new technology garnering share rather than the market growing per se.
The new study says it provides in-depth market segmentation based on the product of each major company (Symplicity, EnligHTN, OneShot, V2, Paradise, TIVUS, Bullfrog, Surround Sound 360), technology (Radiofrequency, Ultrasound, Micro-Infusion, and others) and geography (North America, Europe, the Asia-Pacific and RoW).
The research comprehensively examines the trends and current developments, market opportunities, the key factors driving and restraining the demand for the RDN devices. Porter’s 5 forces analysis and PESTLE analysis are also included. Furthermore, the report profiles the leading players, recent industry developments as well as various business strategies adopted by these behemoths.
The report is entitled: Renal Denervation Devices Market – Global Industry Analysis, Size, Share, Growth, And Forecast, 2012 – 2021, and costs US$ 4,595.00.